Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Lumbar Intervertebral Disc Degeneration
jRCTs031180436Active, not recruiting
- Sponsor
- Kanagawa Prefectural Government
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetylcysteine in degenerative disc disease (DDD) (3 arms), sponsored by Kanagawa Prefectural Government. Primary endpoint: MRI signal change in lumbar intervertebral discs. Started Mar 2021; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on jRCTs031180436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180436.